review on glp-1 agonists and psychiatric effects The expanding role of receptor agonists: a narrative of current evidence future directions GLP-1 receptor agonists are not
Description
Triposkiadis F, Karayannis G, Giamouzis G, Skoularigis J, Louridas G, Butler J
| Placebo | 2.5 | 25 | 10 | 3 | 1 | 2
Sotk, M., Clark, M., Suur, B
Diabetes Med (2003) 20(6):5067
1993Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain
